Free Stories

Latest Issue of OR Manager
May 2024
Home Free Stories

Keynote: Turn your workplace into a WOWplace

Editor's Note The OR Business Management Conference opened on Monday, May 16, with a riveting presentation on how to lead teams to success by turning the workplace into a WOWplace—an innovative concept that calls on leaders to find that something that will create a work environment that employees will not…

Read More

By: Tarsilla Moura
May 16, 2022
Share

OR Manager’s OR Business Management Conference kicks off

Editor's Note The OR Business Management Conference opens today! We are celebrating the 10th year we get to bring together business managers, financial directors, administrators, and C- and D-suite executives involved in running the logistics of the surgical suite. This is the only conference that is focused on driving efficiency…

Read More

By: Tarsilla Moura
May 12, 2022
Share

Report: Profession facing shortage of 450,000 nurses by 2025

Editor's Note According to a McKinsey & Company report, titled “Assessing the lingering impact of COVID-19 on the nursing workforce” and published on May 11, the nursing profession in the US will be facing a shortage of 200,000 to 450,000 of RNs “available for direct patient care” by 2025, Becker’s…

Read More

By: Tarsilla Moura
May 12, 2022
Share

Nurses’ march to shine light on workplace violence, staffing

Editor's Note A peaceful nurses’ march protest, called United “Million” Nurses March and sponsored by Nurses Against Violence, is set to take place in Washington DC on May 12, according to HealthLeaders February 17. The protest is set to focus on two key issues plaguing the profession: workplace violence and…

Read More

By: Tarsilla Moura
May 10, 2022
Share

Sponsored Message

Call for OR manager focus group participation

Editor's Note Rose O. Sherman, RN, EdD, NEA-BC, FAAN, emeritus professor at Florida Atlantic University, will be keynoting a session at the OR Manager Conference in Denver and doing a pre-conference workshop on perioperative recruitment and retention. In preparation for these sessions and to ensure that your biggest leadership challenges…

Read More

By: Tarsilla Moura
May 9, 2022
Share

Risk of hearing loss after COVID-19 vaccination inconclusive

Editor's Note According to JAMA Network May 3, two recent studies examined the risk of sudden sensorineural hearing loss (SSNHL) after COVID-19 vaccination; however, the statistical value of the US-based study was not significant and the absolute risk remains inconclusive. In the first study, JAMA explains, COVID-19 vaccination was associated…

Read More

By: Tarsilla Moura
May 5, 2022
Share

Sponsored Message

Report: 20% of US rural hospitals risk closing, losing services

Editor's Note According to a Bipartisan Policy Center report, titled “The Impact of COVID-19 on the Rural Health Care Landscape” and published on May 4, 441 out of 2,176 rural hospitals in the US—just over 20%—“face three or more risk factors, putting them at risk of service reduction or closure,”…

Read More

By: Tarsilla Moura
May 5, 2022
Share

CMS: HHS extends risk adjustment for telehealth, telephone COVID-19 services

Editor's Note On April 29, the Centers for Medicare & Medicaid Services (CMS) updated an April 2020 “Risk Adjustment Telehealth and Telephone Services During COVID-19 FAQs” notice to extend telehealth and telephone-only services in the Department of Health and Human Services (HHS) risk adjustment program, the American Hospital Association (AHA)…

Read More

By: Tarsilla Moura
May 4, 2022
Share

FDA issues Class 1 recall of COVID-19 rapid test

Editor's Note The Food and Drug Administration (FDA) announced on March 28 a Class 1 recall of the Point of Care Celltrion DiaTrust COVID-19 Ag Rapid Test “because it may have been distributed to unauthorized laboratories,” the American Hospital Association (AHA) May 2 reports. A Class 1 recall is “the…

Read More

By: Tarsilla Moura
May 3, 2022
Share

Study: COVID-19 vaccine effectiveness in children varies by age, variant

Editor's Note According to a multi-institutional study from the Centers for Disease Control and Prevention, titled “Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years” and published on March 18, two doses of the Pfizer-BioNTech COVID-19 vaccine…

Read More

By: Tarsilla Moura
May 2, 2022
Share
Live chat by BoldChat